OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
Clinical trial NCT02988882 · COMPLETED
Trial details
- NCT number
- NCT02988882
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-04-27
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.